Genscript Biotech

Genscript Biotech Rule of 40

The Rule of 40 of Genscript Biotech (1548.HK) as of Oct 9, 2026 is 1,192.55 %. In the previous year, Rule of 40 was 7.63 % — a change of 15,532.54% (higher).

Rule of 40

1,192.55 %

YoY

15,532.54%

Last updated:

Rule of 40 of Genscript Biotech is 2025 1,192.55 % . Rule of 40 of Genscript Biotech was 2024 7.63 % . It decreases by 15,532.54% higher compared to the previous year.

The Genscript Biotech Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
53.55 USD
Jan 1, 2019
-29.72 USD
Jan 1, 2020
-9.35 USD
Jan 1, 2021
-65.90 USD
Jan 1, 2022
-154.41 USD
Jan 1, 2023
-5.75 USD
Jan 1, 2024
7.63 USD
Jan 1, 2025
1,192.55 USD
The Genscript Biotech Rule of 40 history
YEARRule of 40YoY
1,192.55 %+15,532.54%
7.63 %-232.68%
-5.75 %-96.28%
-154.41 %+134.30%
-65.90 %+604.65%
-9.35 %-68.53%
-29.72 %-155.51%
53.55 %-9.20%
58.98 %+9.11%
54.05 %+48.28%
36.45 %—
Access this data via the Eulerpool API
Get Free API Key

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

Rule of 40 of Genscript Biotech is 1,192.55 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API
Get Free API Key

Quality — Genscript Biotech

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — Genscript Biotech